
London, UK — October 28, 2026 — We are thrilled to welcome Dr. Anji Wijekoon as the newest member of our Engineering team, taking on the role of our AI Engineer.
Anji holds a PhD in Artificial Intelligence from Robert Gordon University, where she developed multimodal AI architectures for interpreting complex sensor data. She brings extensive experience across software engineering, healthcare technology and AI research, including developing electronic health record systems for NHS hospitals and research appointments at Robert Gordon University and University College London, where she worked on explainable AI and computer vision for surgery.
Anji joins Panda Surgical at an exciting stage in our development. From the outset, our vision has been to bring together artificial intelligence and robotics to transform surgery. Anji will help accelerate our work in AI and computer vision, bringing us closer to the next generation of intelligent surgical systems.
‘I am delighted to join the Panda Surgical team. I am excited to integrate AI and computer vision into Panda’s handheld robotics ecosystem, bringing real-time assistance to neurosurgery.’
- Anji Wijekoon
‘We’re very excited to welcome Anji to the team. She brings a wealth of experience and fresh perspectives at a really exciting time for Panda. Our vision is to combine AI and robotics to make surgical expertise more accessible, bringing the knowledge and experience of the world’s best surgeons into every operating theatre, so that every patient can benefit from the highest standards of care. Anji will play an important part in making that vision a reality.’
- Prof. Hani Marcus, Panda Surgical CMO
About Panda Surgical
Panda Surgical, a University College London spinout, is developing the world’s first dexterous robot for minimally invasive neurosurgery, offering surgeons enhanced dexterity and decision-support making these complex operations safer, more effective, and more widely adopted.
For further information, please contact: contact@panda-surgical.com
We welcome conversations with clinicians, hospitals, researchers, patient organisations and partners who share our ambition.

